MedPath
NMPA Approval

Peramivir Injection

国药准字H20249216

October 29, 2024

Drug Information

帕拉米韦注射液

注射剂

15ml:0.15g(按C₁₅H₂₈N₄O₄计)

化学药品

October 29, 2024

Company Information

Applicant Company

陕西省西安市高新区新型工业园创新路7号

Manufacturing Company

陕西省西安市高新区新型工业园创新路7号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

帕拉米韦注射液 - NMPA 批准文号 | MedPath